Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
1,658,886
-
Shares change
-
-6,524,735
-
Total reported value, excl. options
-
$3,911,007
-
Value change
-
-$15,365,244
-
Number of buys
-
24
-
Number of sells
-
-4
-
Price
-
$2.36
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2017
31 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2017.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,658,886 shares
of 67,604,359 outstanding shares and own 2.45% of the company stock.
Largest 10 shareholders include FRONTIER CAPITAL MANAGEMENT CO LLC (472,555 shares), WASATCH ADVISORS INC (278,567 shares), TPG Group Holdings (SBS) Advisors, Inc. (249,620 shares), Alyeska Investment Group, L.P. (139,196 shares), Vanguard Group Inc (105,941 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (78,886 shares), BlackRock Inc. (41,962 shares), UBS Group AG (38,022 shares), Ausdal Financial Partners, Inc. (29,650 shares), and WEDBUSH SECURITIES INC (29,509 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.